Home/Filings/4/0001728117-23-000028
4//SEC Filing

Carter Laura 4

Accession 0001728117-23-000028

CIK 0001728117other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 5:23 PM ET

Size

5.4 KB

Accession

0001728117-23-000028

Insider Transaction Report

Form 4
Period: 2023-03-20
Carter Laura
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-20+157,500157,500 total
    Exercise: $1.21Exp: 2033-03-19Common Stock (157,500 underlying)
Footnotes (1)
  • [F1]25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001858178

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:23 PM ET
Size
5.4 KB